Ubs Asset Management Americas Inc Avidity Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 348,841 shares of RNA stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
348,841
Previous 350,365
0.43%
Holding current value
$10.2 Million
Previous $14.3 Million
11.95%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RNA
# of Institutions
255Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$310 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$269 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$252 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$237 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$205 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.52B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...